Genomics and bioinformatics for one. Identifying specific cancer tumor-specific gene mutations on a per-patient basis is happening today in small batches. Thi

Genomics and bioinformatics for one. Identifying specific cancer tumor-specific gene mutations on a per-patient basis is happening today in small batches. This is a direct result of hard-core hacking in sequence alignment software, advances in sequencing hardware, and piles of normal data management tasks being focused on helping flow the necessary information back to pathologists and doctors who make actual treatment decisions on this data. I also think this is a "ground-floor" area in medical treatment. There is just a deluge of previously unknown results and even analysis techniques. This work just wasn't possible before . . .